Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Nestle SA Buys U.S. Medical Foods Firm Pamlab-Reuters


Tuesday, 26 Feb 2013 01:46am EST 

Reuters reported that Nestle SA has agreed to buy U.S. medical foods company Pamlab. Nestle said it was not disclosing terms of the deal. It has also acquired U.S. firm Prometheus Laboratories, which makes tests and drugs for inflammatory bowel diseases, and UK-based CM&D Pharma Ltd, which makes a chewing gum for kidney patients. 

Company Quote

56.547
-0.047 -0.08%
7:40am EDT